MASP2 and pneumococcal infection: Previous studies in pneumococcal infection showed increased disease severity among Masp2-deficient and MASP-2 antibody-treated mice, which was mainly driven by decreased opsonization of bacteria, leading to increased bacterial counts in the peripheral blood [18].